MPM ASSET MANAGEMENT LLC - Q2 2021 holdings

$538 Million is the total value of MPM ASSET MANAGEMENT LLC's 9 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 12.5% .

 Value Shares↓ Weighting
DYN  Dyne Therapeutics, Inc.$104,175,000
+35.5%
4,951,3030.0%19.37%
+30.4%
ITOS SelliTeos Therapeutics, Inc.$94,027,000
-25.8%
3,665,787
-1.1%
17.48%
-28.6%
HOWL NewWerewolf Therapeutics, Inc.$74,716,0004,284,172
+100.0%
13.89%
RPTX SellRepare Therapeutics, Inc.$70,815,000
-11.4%
2,271,177
-12.8%
13.16%
-14.7%
TCRR  TCR2 Therapeutics, Inc.$66,475,000
-25.7%
4,050,8650.0%12.36%
-28.5%
HARP SellHarpoon Therapeutics, Inc.$43,417,000
-35.9%
3,130,267
-3.3%
8.07%
-38.3%
ONCR  Oncorus, Inc.$39,323,000
-0.9%
2,849,4640.0%7.31%
-4.6%
CHMA  Chiasma, Inc.$27,133,000
+51.1%
5,736,2960.0%5.04%
+45.4%
RYTM  Rhythm Pharmaceuticals, Inc.$17,803,000
-7.9%
909,2580.0%3.31%
-11.4%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-08-13
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Chiasma, Inc.24Q2 202119.8%
Aratana Therapeutics, Inc.24Q1 201926.8%
Conatus Pharmaceuticals, Inc.23Q1 20199.7%
Rhythm Pharmaceuticals, Inc.19Q2 202269.9%
Harpoon Therapeutics, Inc.19Q3 202331.9%
Syndax Pharmaceuticals, Inc.19Q3 202014.5%
Radius Health, Inc.17Q2 201876.4%
TCR2 Therapeutics, Inc.17Q1 202329.1%
Proteon Therapeutics, Inc.17Q4 20183.0%
EpiZyme, Inc.15Q4 201635.9%

View MPM ASSET MANAGEMENT LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR/A2023-09-07
13F-HR2023-08-14
42023-06-05
42023-05-24
13F-HR2023-05-12
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-11

View MPM ASSET MANAGEMENT LLC's complete filings history.

Compare quarters

Export MPM ASSET MANAGEMENT LLC's holdings